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This paper examines the challenges and opportunities in establishing and sustaining north–south research
partnerships in Africa through a case study of the UK-Africa Academic Partnership on Chronic Disease. Established
in 2006 with seed funding from the British Academy, the partnership aimed to bring together multidisciplinary
chronic disease researchers based in the UK and Africa to collaborate on research, inform policymaking, train and
support postgraduates and create a platform for research dissemination. We review the partnership’s achievements
and challenges, applying established criteria for developing successful partnerships. During the funded period we
achieved major success in creating a platform for research dissemination through international meetings and
publications. Other goals, such as engaging in collaborative research and training postgraduates, were not as
successfully realised. Enabling factors included trust and respect between core working group members, a shared
commitment to achieving partnership goals, and the collective ability to develop creative strategies to overcome
funding challenges. Barriers included limited funding, administrative support, and framework for monitoring and
evaluating some goals. Chronic disease research partnerships in low-income regions operate within health research,
practice, funding and policy environments that prioritise infectious diseases and other pressing public health and
developmental challenges. Their long-term sustainability will therefore depend on integrated funding systems that
provide a crucial capacity building bridge. Beyond the specific challenges of chronic disease research, we identify
social capital, measurable goals, administrative support, creativity and innovation and funding as five key
ingredients that are essential for sustaining research partnerships.Introduction
There has been a growing number of research partner-
ships between high and low-income regions over the last
two decades [1]. The structures of partnerships are
dependent on the funding organization, the empirical
and geographical focus of the research, the disciplines
involved and the research capacity of collaborating insti-
tutions or groups. This has led to various permutations
involving ‘north-south’ or ‘south-south’ collaborations
with ownership centred either within the northern insti-
tution, southern institution or shared between both [1-4].
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distribution, and reproduction in any mediumbetween countries and complex developmental chal-
lenges, there is a consensus that research partnerships
must play an important role in knowledge production
and the development of global solutions [1-4]. However,
an underlying theme in recent reflections on how re-
search partnerships work is the difficulty of sustaining
and scaling up short-term achievements because of com-
plex micro-political (e.g. power struggles between mem-
bers) and macro political (e.g. the demands of the funding
organization) processes [1-3,5]. It has become important
to record and reflect on the dynamics of partnerships as a
learning process for existing and future partnerships, par-
ticularly those situated within or led from low-income
and low research capacity countries [1,3,6].
In this paper we present a case study of an African-
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on Chronic Disease (hereafter the Partnership), was estab-
lished in 2006 with seed funding from the British Academy.
It aimed to address chronic non-communicable diseases
(hereafter NCDs or chronic diseases) research, practice and
policy for the sub-Saharan African region and for sub-
Saharan Africans in Europe.
Africa has a complex disease burden. Infectious dis-
eases such as malaria, tuberculosis and HIV/AIDS,
neglected tropical diseases like onchocerciasis and schis-
tosomiasis, and nutritional disorders are major causes of
disability and death [7]. At the same time prevalence
rates of chronic non-communicable diseases (NCDs)
such as cardiovascular diseases, cancers and diabetes,
are increasing. While 70% of deaths in Africa can be
attributed to infectious diseases, NCD deaths in men
and women as a whole are higher in sub-Saharan Afri-
can than in virtually all other regions of the world [8].
African health systems are weak and cannot cope with
the cumulative burden of infectious and chronic dis-
eases. There are inadequate numbers of NCD specialists,
health facilities are ill-equipped, medicines are either in-
accessible or expensive, and few countries have devel-
oped policies to address chronic disease care [9-11].
Over the last ten years, health governance and financing
on the continent has been influenced by the growing
number of Global Health Initiatives (GHIs) and the
quest to attain the Millennium Development Goals. This
has had a major impact on how governments, health
policymakers and researchers set and tackle local health
priorities. At least 80% of health financing has focused
on infectious disease and capacity for NCD care is weak
[12]. Similarly, health research in many countries focuses
predominantly on infectious diseases, and particularly
on HIV/AIDS [7,10]. Yet, NCDs, as UN Secretary Gen-
eral Ban Ki-Moon has argued, constitute ‘a public health
emergency in slow motion’ [13], and continued neglect
of their public health impact will significantly undermine
attainment of the MDGs [13,14]. Since the publication
of the 2005 WHO report, Preventing Chronic Diseases.
A vital investment [15], there has been increasing em-
phasis on the urgent need for creative and cost-effective
solutions in the African region and a strong consensus
that multi-stakeholder partnerships can produce these
kinds of solutions [14,16]. The idea for the chronic dis-
ease partnership was developed within this context.
African-centred chronic disease partnerships exist, al-
though they are few in number compared to infectious
disease partnerships in the region and chronic disease
initiatives in Europe and North America. The majority
are funded and led by Euro-American institutions. Some
chronic disease partnerships in Africa have focused on
single chronic conditions in single countries, for ex-
ample diabetes in Ghana [17] or Cameroon [18]. Othershave focused on single conditions across a number of
African countries or across the global context with rep-
resentative African countries. Key examples include the
mental health and poverty project (MHaPP), which fo-
cuses on Ghana, Zambia, Uganda and South Africa [19]
and the International of Asthma and Allergy in Child-
hood (ISAAC) Phase II, which gathered data on asthma
in children across 30 sites in 22 countries including rural
Ghana [20].
There is an emerging trend of African-centred chronic
disease partnerships publishing their experiences. Recent
papers have focused on a UK-Cameroon partnership to
establish a national diabetes care model [18], a UK-
Botswana partnership on public health, including a focus
on epilepsy [21] and on a UK-Ghana partnership on
stroke care [22].
The partnership, described in full below, was different
from existing chronic disease partnership at three levels.
First, we focused on a range of important chronic dis-
eases across a number of African countries, as well as
for African communities living in Europe. Secondly, as
part of our annual reporting commitments to our
funder, The British Academy, the lead partners had to
monitor and evaluate progress against our goals—there-
fore reflexivity was built into project management from
the beginning of the project. Finally, we had limited
funding which prevented collaborative research. In the
following sections we present criteria against which the
achievements of any research partnership may be evalu-
ated and then apply these in a detailed case study of the
Partnership. We identify the elements required for sus-
taining successful chronic disease research partnerships
within a regional context where infectious disease re-
search, practice and policy are prioritised. We then re-
flect on the broader lessons for research partnerships.
Conceptual framework
A number of frameworks exist for evaluating the process
and outcomes of partnerships. Some focus on multi-
stakeholder collaborations such as partnerships between
donors, governments and research institutions [3],
others focus on academic or research partnerships
[2,5,23]. Our evaluation of the successes and challenges
of the Partnership is informed by eleven key principles
of successful research partnerships outlined by Maselli
et al. (2005) [5] (see Table 1). The Maselli et al. concep-
tual framework focuses on research partnerships. Its
principles are captured in other discussions of establish-
ing and sustaining research partnerships, particularly
within the African context [6]. We also draw on broader
discussions within public health on the ‘collaboration
continuum’ where partnerships thrive through a
“balanced division of labor and resources” that might
begin “as a grant at one end; progress to a “transactional
Table 1 Criteria for developing successful communities of
research excellence
1. Decide on objectives together
2. Build up mutual trust
3. Share information, develop networks
4. Share responsibility
5. Create transparency
6. Monitor and evaluate collaboration
7. Disseminate the results
8. Apply the results
9. Share profits equitably
10. Increase research capacity
11. Build on achievements
Source: (Masselli, Lys and Schmid (2005) [5].
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common goal; and culminate in an “integrative stage”
characterized by merging resources to generate a new
identity” (McRobbie and Kolbe, 2009, p. 3) [24]
(Figure 1). Similar three-stage models are proposed else-
where, with the consensual assumption that partnerships
start small with seed funding and graduate through in-
ternal creativity and external financial support to large-
scale long-term projects or institutions [3,6]. The con-
cept of a ‘collaborative continuum’ is essential to our
analysis because it places emphasis on a project in pro-
gress and of the importance of understanding the fine
balance of ‘labour and resources’ that makes the part-
nership work at each conceptual and/or operational
stage.
The UK-Africa academic partnership on chronic
disease: background
The UK-Africa Academic Partnership on Chronic Dis-
ease was established in 2006 with funding of £29,166
from the British Academy’s inaugural UK-Africa Aca-
demic Partnerships (see http://www.britac.ac.uk/fund-
ing/awards/intl/africapartnerships.html). The project was
conceptualized and drafted by the first author (AdGA),
developed by the first and second (DKA) authors, and
fine-tuned through consultation with a group of 15 UK
and Ghanaian academics. It was developed specifically
for the British Academy’s call for grant proposals forGrant  
Stage 
(Partnerships start as 
grants)
Duration: short term 
Transactional    
            Stage 
            (Partners combin
          resources toward a
        common goal)
   Duration: 3-5 years 
Figure 1 The Collaborative Continuum. Source: Adapted from McRobbieUK-Africa academic networks based on ‘themes of com-
mon interest’. The project was co-owned by the authors’
institutions: University of Cambridge (AdGA) and Uni-
versity of Ghana (DKA). However, the British Academy
stipulated that the UK-Africa academic partnerships
grants would be held and managed by the UK principal
partner’s institution. Operationally, the grant—of
£30,000 or less to be spent over three years—could not
fund original collaborative research.
The initial proposal group came from different disci-
plines but all members conducted research on chronic
disease in Ghana, West Africa and South Africa or in
the UK among African or Asian populations (see Table 2
). 16 members had worked or networked together in
various capacities prior to the start of the project. Long-
term friendships and working relationships existed be-
tween a subset of this group. AdGA and DKA, for ex-
ample, had a ten year working relationship, which
included research on diabetes and hypertension in
Ghana in the late 1990s [25]. Similar long-term working
relationships existed between London-based and Accra-
based researchers. Social familiarity, openness and trust
were key components of the development process.
Our theme of common interest was ‘Africa’s neglected
chronic disease burden’. We made a theoretical and em-
pirical case for the necessity of an interdisciplinary network
on chronic disease based on the three well-documented
challenges in chronic disease research that are linked to the
broader political economy of health research in Africa:
1. the recognition that Africa had a significant NCD
burden [15],
2. the fact that the chronic disease burden was a
complex public health problem given its
co-existence with a significant burden of infectious
communicable diseases [9], and
3. the consensus on a need for interdisciplinary
research and for particular contributions from the
social sciences and humanities [9,15,26].
The partnership had four goals:
1. To integrate social and biomedical science research
on chronic diseases of public health significance ine
  
Integrative  
               Stage 
(partnership resources  
             are merged into a new  
            identity) 
Duration:>10 years 
and Kolbe, 2009 [24] and Whitworth et al., 2008 [3].
Table 2 Evolution of the partnership, 2006—2010
End of Year 1 (2007) End of Year 2 (2008) End of Year 3* (2010)
Burkina Faso (1) Cameroon (3) Cameroon (3)
(Med - 1) (Anth-1; Ling -1; Psy-1) (Anth-1; Ling -1; Psy-1)
Ghana (10) Ghana (12) Ghana (13)
(Anth-1; B.Sci -1;Geog-1; Psy-2; Med-4; Nutr-1) (Anth-1; B.Sci -1;Geog-2; Psy-2;
PubH-1; Med-4; Nutr-1)
(Anth-1; B.Sci -1;Geog-2; Pol-1;
Psy-2; PubH-1; Med-4; Nutr-1)
Nigeria (2) Kenya (1) Kenya (1)
(Med -2) (PubH-1) (PubH-1)
UK (10) The Netherlands (1) The Netherlands (1)
(Anth-1; Med-2; Nutr-1; Psy-5; Soc-1) (PubH-1) (PubH-1)
Total number: 23 Nigeria (3) Malaysia (1)
(Med-3) (Anth-1)
South Africa (1) Nigeria (4)
(H.Sci-1) (Med-3; Pol-1)
UK (14) South Africa (1)
(Anth-1; Hsci-1;Med-4; Nutr-3; Psy-5) (H.Sci-1)
Total Number: 35 UK (15)
(H.Sci-1;Med-5; Nutr-3; PubH-1; Psy-5)
US (3)
(Med-1; HSci-2)
Total Number: 42
Key: Anth – Anthropology; B.Sci – Biological Sciences; Geog – Geography; H.Sci – Health Sciences; Med – Medicine (including Psychiatry); Nutr- Nutrition;
Pol – Policy; Psy – Psychology; PubH – Public Health; Soc – Sociology;
Note: Profile excludes postgraduate student members from Ghana (5), UK (5), Denmark (2) and the US (1) who joined in Years 1 and 2.
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through collaborative research between partners;
2. To influence chronic disease policies in Africa by
disseminating evidence-based research and
intervention to policy makers;
3. To offer postgraduate teaching, training and support
in Africa and in the UK on Africa-centred chronic
disease through teaching exchanges, research
internships and co-publishing;
4. To disseminate partnership research and related
activities to academic, health practitioner/policy and
lay audiences through a partnership website, annual
meetings and joint publications.
These goals were refined over the partnership’s four-
year history in response to logistical and professional
challenges (see following sections).
Structure
We began with 17 members, including the UK and Af-
rica principal partners. We aimed for an interdisciplinary
structure with the social sciences dominating to redress
the medical dominance in chronic disease research in
the region (see Table 1 and Table 2). During the period
of funding (2006–2010) the network expanded to in-
clude members from West, East and South Africa, as
well as from Europe and the United States (see Table 2).We maintained the interdisciplinary focus and secured
the membership of humanities scholars and of policy-
makers. We also lost some of our initial members due to
their changing professional circumstances. Of the ori-
ginal 17 members named on the initial grant application,
only 9 remained actively involved in partnership activ-
ities by March 2010, and only 5 of the original group
were members of the core working group.
Measuring engagement
At the start of the project the lead partners (AdGA and
DKA) set up three levels of engagement based on their
knowledge of the challenges in managing research part-
nerships in Ghana. By offering flexibility in participation
and tracking members’ participation at clearly defined
levels of engagement we aimed to facilitate the process
of monitoring and evaluating project activities and goals,
as well as to fulfill our annual reporting commitments to
the British Academy. These levels of engagement were
presented and discussed at our first workshop in Accra
in 2007 where 60% of members (n = 23) were present
(see Table 3).
 Level 1, the lowest, involved committing to at least
one goal over the funded life of the project. This
could include: (1) attending and/or presenting at
one annual meeting (Goal 2 and 4); or (2)
Table 3 Level of Engagement of Partnership members,
2007–2010
Activity Total
membership
Percentage
participation
1st Annual workshop (Accra, 2007) 23 14 (60%)
2nd Annual workshop (LSE, 2008) 30 14 (47%)
BA/RS/GAAS International Conference
(Accra, 2009)
35 15 (43%)
Monash Chronicity Conference
(Kuala Lumpur, 2010)
42 9 (21%)
Globalization and Health Special Issue
(2009/2010)
42 17 (40%)
Ghana Medical Journal Special Issue
(2009-2010)
42 [24 Ghana
experts]
10 [of 24
experts] (42%)
Grant applications (2008 – 2010) 42 10 (24%)
Table 4 Core working group and individual contributions
Goal 1 Goal 2 Goal 3 Goal 4
Juliet Addo +++ +++ − +++
Charles Agyemang +++ +++ +++ +++
Pascale Allotey* ++ +++ − +++
Kofi Anie* ++ +++ − +++
Daniel Arhinful* +++ +++ − +++
Lem Atanga +++ ++ ++ ++
Catherine Campbell* ++ ++ − +++
Ama de-Graft Aikins* +++ +++ +++ +++
Catherine Kyobutungi ++ ++ ++ +++
Olugbenga Ogedegbe +++ +++ +++ +++
Emma Pitchforth ++ ++ − +++
Nigel Unwin +++ +++ ++ +++
Key: * members of the proposal group; +++ contributed to all aspects of the
goal; ++ contributed to some aspects of the goal; - no contribution to the
goalGoal 1: Publishing in the two special issues (at least 1); co-writing research
proposals (at least 1 of 4)Goal 2: Dissemination of policy-relevant research
through: (1) meeting presentations; (2) publications.Goal 3: Seminar lecture;
research support; co-authoring publications with post-graduate studentsGoal
4: Attending annual meetings (at least 1); presenting/chairing at annual
meetings (at least 1).
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exchange in the life of the project (e.g. a UCL based
partner teaching at LSE; a KNUST researcher
teaching at the University of Ghana, Legon) (Goal
3); or (3) contributing to one project publication
(Goal 1).
 Level 2 involved committing to at least two goals:
(1) presenting at one or more meetings (Goals 2 and
4); and (2) committing to at least one teaching
exchange (international or non-international) (Goal
3), or contributing to one project publication (Goal
1).
 Level 3 involved committing to at least three goals.
It was envisaged that partners committed to Level 3
would form the core working group around whose
empirical work the project would be built over the
three years of BA funding. It was also envisaged that
as part of Goal 1, this working group would
collaborate on grant proposals to secure funding to
scale up partnership activities post BA funding.
Based on the levels of engagement in key project activ-
ities recorded over the funded life of the project
(see Table 4), about 23% of the partnership (10 out of
the total membership of 44) could be categorised as ac-
tive members, the ‘core working group’ that was com-
mitted to the vision of the partnership and contributed
valuable time, skills and resources to the activities and
development of the partnership (Table 3). The remaining
constituted a mix of supportive members (average to
low engagement) and passive members (low to no
engagement).A description of the partnership’s achievements
and challenges
We describe the achievements and challenges across the
four partnership goals.Goal 1: To integrate social and biomedical science
research on chronic diseases of public health significance
in Africa and for African communities in the UK through
collaborative research between partners
Goal 1 was the most difficult to achieve during the
funded period for two reasons. Our funding could not
accommodate collaborative research and applications for
funding to scale up our activities were unsuccessful.
Three grant applications were submitted to funders.
The first two applications focused on developing chronic
disease prevention interventions through participatory
education. The first was submitted to Wellcome Trust in
April 2008, with an African partner as Principal Investi-
gator (PI) and three Africa-based and UK-based mem-
bers as co-PIs. The second was submitted to ESRC in
December 2008 with a UK-based PI, and seven Africa-
based and Europe-based members as co-PIs and re-
search consultants. Neither application was successful
despite positive reviews from the Wellcome reviewers
and a ‘good value for money’ endorsement from the
ESRC reviewers. The third unsuccessful grant proposal
was submitted to the Netherlands Organisation for Sci-
entific Research (NWO) call for proposals for its Inte-
grated Programme Scheme. The proposal was led by a
Europe-based member, with four Africa-based and
Europe-based members as co-PIs. Co-applicants for the
three grants were all members of the core working
group.
In light of these unsuccessful applications we adopted
two creative strategies to develop active research pro-
jects. The first strategy was to draw on northern
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jects. The first project was a collaboration in 2009 be-
tween Academic Medical Centre (AMC), University of
Amsterdam (through last author CA) and African Popu-
lation Health Research Centre (APHRC) (through core
working group partner Dr Catherine Kyobutungi). The
project focused on hypertension in a Nairobi slum. This
resulted in the production of a University of Amsterdam
Masters thesis. A manuscript on prevalence, awareness,
treatment and control of hypertension in Nairobi, based
on the thesis, is currently in preparation for journal pub-
lication. The second project was a collaboration in 2010
between the School of Medicine, New York University
(NYU) (through fourth author GO) and the Regional In-
stitute for Population Studies (RIPS), University of
Ghana (through first author AdGA). The project exam-
ined the feasibility of establishing cardiovascular disease
interventions in churches in Accra. Funding from the
NYU Capstone Programme enabled four Global Health
Masters students to conduct fieldwork with RIPS Mas-
ters students in Accra. The project led to an MPH pro-
ject report and a co-authored publication in the Bulletin
of the WHO [27].
The second strategy was to develop south-south col-
laboration through low-cost pilot studies that could be
conducted in partner African countries and could feed
into the postgraduate training goals as well as research
proposals for funding. Two collaborations emerged from
this. The first pilot project was conducted between part-
ners based at the University of Ghana (UG) and focused
on body image, perceptions and management in the UG
community within the context of obesity and chronic
diseases. Results of the project were presented at the
2010 UG Faculty of Social Studies Colloquium [28]. A
manuscript is currently in preparation for journal publi-
cation. The second project was a collaboration between
partners based at the University of Dschang, Cameroon
and UG. The project examined media representations of
chronic diseases in Ghana and Cameroon; postgraduate
students at the University of Dschang assisted in gather-
ing and analysing the data. Results of the project were
presented at the 2010 UG Faculty of Social Studies Col-
loquium [29]; a manuscript has been submitted for peer
review publication [30].
Goal 2: To influence chronic disease policies in Africa by
disseminating evidence-based research and intervention
to policy makers
We adopted three strategies to achieve goal 2. First, we
actively invited policymakers and members of donor
agencies to all partnership workshops to participate as
speakers or session chairs. Second, all workshop reports
and proceedings were disseminated to policymakers
based in Ghana, UK and Malaysia. Finally we activelysought the participation of policymakers in the produc-
tion of our journal special issues, either as contributors
or as reviewers. We secured the participation of policy-
makers and donors from the Ghana’s Ministry of Health,
Ghana Health Service, Malaysia’s Ministry of Health,
WHO-Ghana Office, WHO-Afro, WHO, UNAIDS-
Nigeria Office, Royal Netherlands Embassy and UK’s
DFID to our 2007 workshop and 2009 and 2010 inter-
national conferences. The 2007 workshop report was
disseminated to Ghana’s Ministry of Health and Ghana
Health Service. The Ghana Medical Journal special
issue, which was informed by the 2007 Accra workshop,
actively involved local policymakers as authors and
reviewers. A local policymaker was invited to join the
guest editorial team; he also contributed a review paper
on trends and challenges in non-communicable disease
policymaking in Ghana [31].
There was a major limitation to Goal 3. While we were
able to disseminate our meeting outputs to local, re-
gional and international policymakers, we were unable
to monitor how the partnership outputs were used by
policymakers. Limited funding prevented the monitoring
and evaluation of processes external to the membership
network.
Goal 3: To offer postgraduate teaching, training and
support in Africa and in the UK on Africa-centred chronic
disease through teaching exchanges, research internships
and co-publishing
Logistical and funding challenges led to minor restruc-
turing of Goal 3. The focus on teaching exchanges had
to be refined because UK and African universities oper-
ated different academic schedules and it was difficult to
synchronise timetables of potential visiting lecturers and
host institutions without incurring significant costs. We
re-conceptualised teaching exchanges as opportunistic
seminars, whereby UK or US partners visiting African
countries on regular research activities were invited to
give lectures or seminars at partner university depart-
ments. However, we were unable to facilitate these semi-
nars, until after the funding period when two partners—
one Europe-based, the other US-based—gave invited lec-
tures at RIPS in 2011.
The workshops offered an alternative opportunity for
postgraduate students to meet and network with part-
ners. Therefore, we actively encouraged postgraduate
participation in our workshops. Postgraduate student
members conducting research on chronic diseases in Af-
rica presented at partnership workshops in Ghana
(NMIMR, 2007) and the UK (LSE, 2008).
The partnership facilitated two research internships:
the aforementioned University of Amsterdam MSc re-
search project based at APHRC, Nairobi and the NYU
MPH group research project based at RIPS. Both
Table 5 Regional participation in Partnership Journal
Special Issues
#papers #authors Africa} Asia Europe US
Globalization and
Health SI (2010)
8 31 7 1 17 6
Ghana Medical
Journal SI (In Press)
10 20 12 – 7 1
Total 18 46* 19 1 20 5
*5 partners contributed to both Special Issues(SIs); }Cameroon, Ghana, Nigeria,
Kenya; Malaysia; Netherlands, Denmark; UK.
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the masters students with in-kind support from the Afri-
can institutions.
The focus on co-publishing was the best realized strat-
egy out of the three. We actively sought postgraduate
contributions to our journal special issues and assisted
some postgraduates in improving their papers for publi-
cation. Ten (10) postgraduate student members pub-
lished papers in the two partnership flagship Special
Issues in Globalization and Health (N = 4) and the
Ghana Medical Journal (N= 7). Three postgraduates co-
wrote their papers with partnership members. One post-
graduate published in both issues. Of the 10 postgraduate
students, 5 were based in Ghana and 5 in Europe. The
NYU–RIPS collaboration, led to a co-publication be-
tween 2 core working group members, 4 NYU MPH stu-
dents and 1 RIPS MPhil student [27].
Goal 4: To disseminate partnership research and related
activities to academic, health practitioner/policy and lay
audiences through a partnership website, annual
meetings and joint publications
Goal 4 yielded the greatest consistent success. We orga-
nised two major partnership workshops in Ghana
(NMIMR, 2007) and London (LSE, 2008) and co-
organised an international conference with Monash Uni-
versity in Malaysia (2010). In 2009 the partnership
formed the basis for an international conference funded
by the British Academy and the Royal Society in collab-
oration with the Ghana Academy of Arts and Sciences.
These annual meetings attracted a large number of par-
ticipants from diverse communities including research-
ers, practitioners, patient groups, policymakers and lay
society. The workshops led to major publishing
opportunities.
The 2008 partnership workshop led to an invitation to
submit workshop proceedings as a special issue to the
online open access journal Globalization and Health, by
the journal’s co-Editor-in-Chief and fourth author, EP.
The issue titled “Africa’s Disease Burden: local and glo-
bal perspectives” was published in 2010 and guest edited
by core working group members based in Africa, Asia
and Europe [32]. Eight papers focused on major areas of
Africa’s chronic disease burden including cardiovascular
and risk factors among African migrant populations in Eur-
ope [33], co-morbid relationships between diabetes, tuber-
culosis and ART [8], diabetes experiences in Dar-es-Salaam
[34], the social-cultural context of CVD in Africa [35],
sickle cell disease [36], mental illness experiences and care
in rural Ghana [37], care-giving in the context of HIV/AIDS
in Kenya [38] and developing prevention strategies in
Ghana and Cameroon [39]. Four (4) papers were based on
original individual research by authors, with three stem-
ming from postgraduate research; 4 papers were based onreviews conceptualized for the special issue. Twenty-nine
(29) authors contributed to the issue: of these 6 were based
in Africa, 16 based in Europe, 6 based in the US and 1
based in Asia. Two of the Globalization and Health publi-
cations [31,32] are highly accessed; each having been
accessed more than 10,000 times.
A second special issue by the Ghana Medical Journal
is in press. The issue titled “Ghana’s chronic non-
communicable disease burden” is guest edited by core
working group members based in Ghana, Europe and
US. Ten papers submitted by members, including post-
graduate students, focused on the epidemiology of
asthma [40], hypertension [41] and stroke [42], the bur-
den of mental illness [43], ageing and chronic diseases
[44], experiences of type 1 diabetes [45] and terminal
chronic conditions [46], household burden of chronic
diseases [47], lay knowledge of the major chronic dis-
eases [48] and local policy responses to the burden [31].
Five papers were based on original individual research; 5
papers were based on reviews conceptualized for the
special issue. Nineteen (19) authors contributed to the
issue: of these 11 were based in Ghana, 7 in the UK and
1 in the US.
Table 5 presents the levels of regional participation in
our publishing projects. Out of a cumulative total of 46
authors, 42% were based in African institutions, 44% in
European institutions and 11% in US institutions. Table 6
presents the disciplinary background of contributing
authors for the two special issues. Out of the cumulative
total of 43 authors, 65% were social scientists, and 33%
were medical scientists. Five of the six review papers that
were conceptualized specifically for the special issues
were co-authored by multi-institutional and multi-
disciplinary teams. Two of these had authors based in
Ghana.
The British Academy commissioned and published a
research report based on the 2009 Accra Conference
[10]. The report was launched at the LSE, on 1st June
2011, to stimulate interest in and discussion of Africa’s
chronic disease problems ahead of the UN High Level
Meeting on NCDs in September 2011 [49]. A follow-up
launch was held in Accra in April 2012.
Table 6 Disciplines of contributing authors to Partnership
Journal Special Issues
#
papers
#
authors
Social
sciences
Humanities Medical
sciences
Globalization and
Health SI (2010)
8 31 25 1 5
Ghana Medical
Journal SI (In Press)
10 20 9 – 11
Total 18 46* 31** 1 14***
*5 partners contributed to both SIs; **3 partners published in both SIs; ***2
partners published in both SIs.
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two new special issues that aimed to address the chal-
lenge of NCDs in low and middle-income countries. A
Globalization and Health issue titled “Chronicity” and
Chronic Health Conditions: Implications for Health and
Health Care is in press.
This issue was guest edited by organisers of the Mon-
ash conference who were based in Africa, Asia, and the
UK. A second special issue in Ethnicity and Health is
titled Culture, Ethnicity and Chronic Conditions: a Glo-
bal Synthesis. This issue is expected to be published in
2013 and is guest edited by partnership members based
in Africa, Asia, the UK and the US.
An evaluation of the partnership’s achievements
and challenges
Building a successful research partnership: enabling
factors and barriers
Table 7 presents an evaluation of our achievements
using the Maselli, Lys and Schmid (2005) criteria [5].
We outline the enabling factors and barriers to achieving
our four goals in order to highlight why and how our
partnership worked.
Jones et al. [2] suggest that partnerships work when
the following factors are present: relations of mutual
trust and respect; responsiveness of northern partners to
southern partner demands; partnership structures do
not add to cumbersome donor requirements; the local
context is understood; the development of projects build
on existing capacities. The majority of the enabling fac-
tors we identified map onto the factors identified by
Jones et al. [2]. The relationships between working group
members were built on trust, mutual respect and open-
ness. Our activities were characterized by operational
flexibility, which was supported by the flexibility and
simplicity of The British Academy’s reporting process.
We applied creative strategies to maximize our minimal
resources, for example in negotiating in-kind support
from southern partner institutions and accessing finan-
cial support from northern partner institutions.
Our barriers were material and conceptual. We lacked
funding to conduct research, to train postgraduate stu-
dents and to evaluate some of our goals. We also lackedadministrative support: the majority of tasks had to be
carried out by a small group of partnership members who
had full-time academic responsibilities. Conceptually, the
partnership goals were over-ambitious; furthermore we
did not develop clear indicators to measure the success of
some of our goals. For example, we did not build appro-
priate monitoring and evaluation processes into our pol-
icy goal. Therefore while we were able to reach
policymakers across three continents through our re-
search dissemination platform, it is difficult to make any
claims about the transfer of knowledge into policymaking.
We identified five key ingredients required to sustain
our partnership (see Figure 2) that may be applicable to
research partnerships generally:
1. Social Capital: A basic definition of social capital is
the shared understandings, values and links
individuals and groups share that engender trust and
collaboration. Theorists make distinctions between
bonding capital (‘trusting and co-operative relations
between members of a network who are similar in a
socio-demographic sense’), bridging capital
(‘relations of respect and mutuality between people
who are dissimilar’) and linking social capital (norms
of respect and networks of trusting relationships
between people who are interacting across explicit,
formal, or institutionalized power or authority
gradients in society’) [50]. The importance of trust
and mutual respect within partnerships (bonding
capital) is emphasized by the majority of reflexive
accounts of sustainable partnerships. Our
partnership thrived, despite funding challenges,
because these elements were present within our core
working group. We also had the added advantage of
accessing support from our funder, The British
Academy, and institutions of our northern partners
(linking capital) which strengthened aspects of
advocacy activities and postgraduate support,
respectively (see Table 7).
2. Measurable goals: Goals have to clearly be
conceptualized, realistically costed and measurable
in order to monitor and evaluate the relationships
between inputs, outputs and outcomes. It helps to
develop indictors for monitoring and evaluating
goals at the inception stage. Beyond their utility in
tracking progress, indicators also enable activities,
responsibilities and expected outcomes to be
transparent to all partners.
3. Administrative support. Administrative support is
necessary for non-technical aspects of partnership
activities. Activities like organizing meetings
(whether face to face or online), writing reports,
searching for grant proposals and developing grant
proposal budgets can be time consuming and
Table 7 Matching Partnership Goals to Criteria for building communities of research excellence
Maselli, Lys and
Schmid (2005)
Partnership
achievement(s)
Enabling Factors Barriers
1. Decide on
objectives
together
Yes A working relationship between the lead partners
and the core working group based on trust, respect
and openness. Good communication access (e.g.
email, phone, annual meetings).
None
2. Build up mutual
trust
Yes Pre-existing relationships between applicants on
original grant. Trust, respect and openness, key
aspects of these relationships.
None
3. Share
information,
develop networks
Yes Good communication channels between partners
(see 1 and 2).
Partnership website was developed but not fully
functional in the first two years due to limited
administrative support (see 4).Openness and flexibility to involve new members
and especially postgraduate students.
Funding for annual meetings created platform for
sharing information and developing networks.
4. Share
responsibility
Yes Shared commitment by core working group
members (see 1,2 and Box 3)
Limited funding and capacity for administrative and
management support. The coordination of tasks and
activities was the responsibility of the lead partners
who had full-time academic responsibilities. As lead UK
partner transitioned from postdoctoral fellowship status
to a full-time lecturing position, the time and capacity
to engage in increased administrative tasks diminished.
5. Create
transparency
Yes Informal and flexible communication approach.
Commitment by lead partners to disseminate
important information, e.g. levels of engagement,
meetings, opportunities for publications, calls for
grant proposals.
None
6. Monitor and
evaluate
collaboration
Yes Reflexivity built into project because of BA reporting
processes.
Lack of clear indicators to measure some goals (e.g.
Goal 2).
Flexibility and simplicity of BA reporting processes. Limited funding and a lack of administrative support
affected the monitoring and evaluation of external
processes (e.g. the impact of policymakers’ participation
in partnership events on policy development)
7. Disseminate the
results
Yes Funding available for annual multi-stakeholder
meetings.
Monitoring and Evaluation indicators were not
systematically outlined at the outset of the project. This
affected the evaluation of goal 2 (the translation of
research dissemination into policy development).
In-kind support from hosting institutions (e.g. fee
waivers for cost of venue, logistical assistance with
publicity).
Access to journal editors through core working
group members’ networks.
8. Apply the results Yes Access to journal editors enabled proceedings of
partnership meetings to reach a wider international
audience
Failure to secure funding prevented the development
of collaborative research in the first three years.
Creative strategies enabled the development of pilot
projects funded by northern institutions
Access to funding (competitive grants and seed
funding) and the administrative capacity of northern
partners’ institutions enabled the development of
collaborative research projects
9. Share profits
equitably
Partially A spirit of openness and inclusiveness enabled
collaboration between northern and African
members as well as senior academics and
postgraduate researchers. Profits (mainly
publications, travel opportunities) were shared by
core working group members.
Lack of funding affected the sharing of some profits
(e.g. international travel to partnership meetings were
not available to all members (see Table 1)
10. Increase
research capacity
Partially Access to northern institutional seed funding Limited funding during first 3 years of partnership.
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Table 7 Matching Partnership Goals to Criteria for building communities of research excellence (Continued)
11. Build on
achievements
Yes Access to in-kind support by African institutions Multiple responsibilities shared by few core working
group members.
Commitment from core working group. Lack of administrative and management capacity is
likely to undermine grant proposal writing by African
partners, especially partners outside Ghana.
Access to seed funding from northern institution to
support US-Ghana research collaboration
Lack of funding may undermine our medium term goal
to establish regular international conferences on
chronic conditions in Africa.Access to in-kind support from African institutions
Access to a competitive grant to support Ghana-
Europe research collaboration
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stretch the capabilities and commitments of
partnership members.
4. Creative and innovative strategies: Openness to new
ways of using existing resources (within the group)
and to securing additional resources (within and
outside the group) can propel a poorly-resourced
research partnership forward. In our experience,
creative strategies are collectively understood,
legitimized and supported when partnerships have
bonding social capital and strategies can be
successful when partnerships develop linking social
capital with external networks and groups with
relevant material resources.
5. Funding. For small scale partnerships to transition
from the grant stage to the integrative stage, funding
is required. The primary route is for partners to
access competitive grants if they have the
appropriate capacity to develop and submit
proposals. Other routes might be to access non-
competitive grants, such as seed funding from
existing funding and academic networks. A recent
alternative has been offered by The Nairobi Report,
an influential document on building capacity in
African universities that was produced through
consultation with UK and African academics [6].
The report advocates “the need for a more
integrated research funding system that can provideFunding  
Creativity and 
innovation 
Social ca
Sustain
Resear
Partners
Figure 2 Five key ingredients for sustaining research partnerships.‘a ladder’ for the progression of good collaborative
research teams from small-scale intensive projects to
test initial research ideas and methodologies to large
scale projects that can provide rigorous evidence”
(p. vii). We are strongly aligned to this view. For
successful small-scale research partnerships that
focus on important research problems that are
marginalized by local and international policymakers
and funders, the progress from small-scale (grant
stage) to large scale projects (integrative stage) must
be actively supported by the initial funders.
The collaborative continuum: moving from the
transactional stage to the integrative stage
Funding from the British Academy ended in 2010 and we
no longer have funding tied solely to the partnership.
Thus, in terms of the collaborative continuum (Figure 1)
we are at the transactional stage in which members of
the core working group are combining resources—time,
research expertise, access to grants—to achieve our goals.
To move from the transactional stage to the integrative
stage, where resources are merged to generate a new
identity [24], we must address at least two challenges.
The first challenge relates to institutional support and
its associated administrative support. Our institutional
arrangements have changed, with LSE Health and RIPS,
rather than Cambridge and NMIMR, providing the insti-
tutional support role. These changes have occurred forAdministrative 
support
Measurable 
goals 
pital
able 
ch 
hips
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ended. Secondly, because the UK principal partner
(AdGA), formerly based at Cambridge, joined RIPS in
2009, with a visiting fellowship at LSE Health in the
same year. Thirdly, because the LSE Health directorship,
has supported the initiative since 2009, and committed
funding and in-kind contributions to partnership activ-
ities. The critical issue is whether this institutional ar-
rangement is the most appropriate for moving the
partnership into the integrative stage. Partnership activ-
ities in the two years following the end of BA funding
have been supported primarily by core working group
members based in four institutions: RIPS, LSE Health,
University of Amsterdam and NYU. This arrangement
whereby the partnership retains an identity as ‘a com-
munity of practice’ [6] with access to support from
southern and northern institutions has worked in con-
crete ways. It has, for example, created the opportunity
for partnership members to collaborate on research
(Goal 1) and to train postgraduates (Goal 3).
A major European Union (EU) grant was secured by a
consortium led by CA in 2011. The project—titled Risk
of Obesity and Diabetes among African Migrants
(RODAM)—focuses on the complex interplay between
environment, lifestyle, (epi)genetic as well as social fac-
tors in type II diabetes and obesity among one
homogenous migrant population (i.e. Ghanaians) living
in Germany, the Netherlands, the UK and their counter-
parts living in rural and urban Ghana. The RODAM pro-
ject will generate relevant results that will ultimately
guide intervention programmes and will provide a basis
for improving diagnosis and treatment among sub-
Saharan African migrants in Europe as well as in their
counterparts in Africa and beyond. The consortium
includes 5 members of the core working group. Three
PhD studentships will be available for students at RIPS
and the Kumasi Centre for Collaborative Research
(KCCR), Kwame Nkrumah University of Science and
Technology. In addition, NYU has provided seed funding
for collaborative research between NYU and UG. Two
core working group members are collaborating on car-
diovascular disease management projects and building
on existing population-based research at RIPS. Graduate
support is built into these projects, with the creation of 4
MPhil studentships and 1 PhD studentship at RIPS.
The partnership also requires administrative and man-
agement support. To date the majority of responsibilities
and tasks have been carried out by a limited number of
core working group members who are full-time aca-
demics. This has often affected the timely development
and delivery of partnership activities. As the partnership
moves into the integrative stage, a budget for adminis-
trative and management support must be built into our
funding applications.The second challenge relates to the kind of ‘identity’
the partnership should develop in the long-term. Our
original set of goals was over-ambitious given our lim-
ited funding. In the absence of partnership-specific fund-
ing, a prudent strategy might be to focus on the two
goals we have successfully achieved: creating a platform
for chronic disease research dissemination, including the
support and dissemination of postgraduate student re-
search. While the RODAM and NYU-UG projects offer
concrete opportunities for core working group members
to collaborate on to achieve research and postgraduate
student training, these projects are not strictly owned by
the partnership.
In the medium term (2012–2015), resources from core
working group members based at RIPS, Amsterdam and
NYU are likely to push the partnership into the integra-
tive stage. This sub-group continues to work together on
grant applications. We have publishing projects in pro-
gress until 2013. The partnership also continues to re-
ceive queries for membership from established
researchers and postgraduates from Africa, UK and US,
suggesting that we provide an important function in the
arena of African-centred chronic disease research. As
our major achievement was making NCD research in
Africa more visible to an international audience, we aim
to build on this by establishing a biennial International
Conference on Chronic Conditions in Africa.
Conclusions
Our research partnership set out to develop a model for
NCD research, postgraduate training and support, policy
development and advocacy over a three-year period. We
achieved major successes with very limited funding. Key
successes included creating greater visibility for NCD re-
search in Africa and supporting African and European
postgraduate students by offering them publication op-
portunities. Our meetings in Ghana, UK and Malaysia
also created the space for researchers to network with,
and disseminate their research to, policymakers.
Our collaborative research goal was not successfully
realized during the funded life of the project due to lim-
ited funding and our failure to secure additional funding.
We were also limited by the lack of administrative sup-
port. However the trust, respect and openness between
the core working group and shared passion for and com-
mitment to developing research solutions for Africa’s
chronic disease burden shaped practical and creative
responses to the challenges we experienced. These ele-
ments of bonding social capital were crucial to the suc-
cess of our partnership during the BA funded phase and
to its sustainability beyond the funded phase.
The importance of funding cannot be underestimated,
however. Over the last two years, the ability of our part-
nership to increase its research capacity and build on its
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accessed by partners in northern institutions. We en-
dorse the recent call for integrated funding systems that
provide a ladder for the progression of ‘good collabora-
tive research teams’ from small-scale projects to large
scale projects [6]. For successful small-scale projects
based on important health and developmental problems
that are marginalised by local and international policy-
makers and funders, it is essential that the progress from
small-scale to large scale projects is actively supported
by the initial funders. The support can be provided
through extra targeted funding the initial funders can
offer themselves or secure from their funding networks.
The support can benefit medium term activities such as
the preparation of further grant proposals and long-term
activities such as administrative tasks, which are crucial
for projects to progress from the grant stage to the inte-
gration stage.
Beyond the specific challenges of sustaining a chronic
disease research partnership, we identified and discussed
the importance of social capital, measurable goals, ad-
ministrative support, creative and innovative strategies
and funding as five key ingredients that are essential for
sustaining research partnerships generally.
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